225 related articles for article (PubMed ID: 26980024)
1. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?
Kadokura A; Frydenlund N; Leone DA; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030
[TBL] [Abstract][Full Text] [Related]
3. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status.
Mitchell B; Leone D; Feller JK; Bondzie P; Yang S; Park HY; Mahalingam M
Melanoma Res; 2014 Dec; 24(6):621-5. PubMed ID: 25211166
[TBL] [Abstract][Full Text] [Related]
4. ZEB and Snail expression indicates epithelial-mesenchymal transition in canine melanoma.
Veloso ES; Gonçalves INN; Silveira TL; Espirito Santo JT; Figueiredo LV; Varaschin MS; Cassali GD; Del Puerto HL; Ferreira E
Res Vet Sci; 2020 Aug; 131():7-14. PubMed ID: 32278962
[TBL] [Abstract][Full Text] [Related]
5. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry.
Yaman B; Kandiloğlu G; Akalin T
Am J Dermatopathol; 2016 Feb; 38(2):113-20. PubMed ID: 26630683
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
Long GV; Menzies AM; Nagrial AM; Haydu LE; Hamilton AL; Mann GJ; Hughes TM; Thompson JF; Scolyer RA; Kefford RF
J Clin Oncol; 2011 Apr; 29(10):1239-46. PubMed ID: 21343559
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.
Wang G; Ma W; Li Y; Jiang Y; Ma G; Zhang X; Meng L; Du J
Eur J Cardiothorac Surg; 2018 Aug; 54(2):237-245. PubMed ID: 29415155
[TBL] [Abstract][Full Text] [Related]
8. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
[TBL] [Abstract][Full Text] [Related]
9. BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin?
Mitchell B; Leone D; Yang S; Khan A; Mahalingam M; Dhingra J
Am J Transl Res; 2016; 8(11):5076-5086. PubMed ID: 27904709
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines.
Tsutsumida A; Hamada J; Tada M; Aoyama T; Furuuchi K; Kawai Y; Yamamoto Y; Sugihara T; Moriuchi T
Int J Oncol; 2004 Nov; 25(5):1415-21. PubMed ID: 15492833
[TBL] [Abstract][Full Text] [Related]
11. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT
Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
13. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of BRAF mutations in localized cutaneous melanoma.
Nagore E; Requena C; Traves V; Guillen C; Hayward NK; Whiteman DC; Hacker E
J Am Acad Dermatol; 2014 May; 70(5):858-62.e1-2. PubMed ID: 24388723
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
Yaman B; Akalin T; Kandiloğlu G
Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015
[TBL] [Abstract][Full Text] [Related]
16. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer.
Fan XJ; Wan XB; Yang ZL; Fu XH; Huang Y; Chen DK; Song SX; Liu Q; Xiao HY; Wang L; Wang JP
Hum Pathol; 2013 Feb; 44(2):173-80. PubMed ID: 22974478
[TBL] [Abstract][Full Text] [Related]
17. The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.
Armengot-Carbó M; Nagore E; García-Casado Z; Botella-Estrada R
J Am Acad Dermatol; 2018 May; 78(5):920-926.e4. PubMed ID: 29307636
[TBL] [Abstract][Full Text] [Related]
18. BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.
Hugdahl E; Kalvenes MB; Puntervoll HE; Ladstein RG; Akslen LA
Br J Cancer; 2016 Mar; 114(7):801-8. PubMed ID: 26924424
[TBL] [Abstract][Full Text] [Related]
19. BRAF and Epithelial-Mesenchymal Transition: Lessons From Papillary Thyroid Carcinoma and Primary Cutaneous Melanoma.
Mitchell B; Dhingra JK; Mahalingam M
Adv Anat Pathol; 2016 Jul; 23(4):244-71. PubMed ID: 27145091
[TBL] [Abstract][Full Text] [Related]
20. The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer.
Jaca A; Govender P; Locketz M; Naidoo R
J Clin Pathol; 2017 Apr; 70(4):331-356. PubMed ID: 27672217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]